Name: Medify
Author: Medify

Question 1

What is Medify?

Accepted Answer

Medify is an integrated ePRO (electronic Patient Reported Outcomes), eSource, and patient engagement platform purpose-built for clinical trials. It combines a patient mobile app, investigator dashboard, and monitor control center in a single system with real-time safety alerts and an immutable audit trail. Medify is the first platform in this category built specifically for Central and Eastern Europe.

Question 2

Who is Medify designed for?

Accepted Answer

Medify serves pharmaceutical companies, Contract Research Organizations (CROs), and research sites conducting clinical trials in Central and Eastern Europe. It is designed as a mid-market alternative to enterprise platforms like Medidata and Veeva, with faster deployment and more accessible pricing.

Question 3

How much does Medify cost?

Accepted Answer

Medify uses a setup fee based on trial complexity plus per-user monthly pricing, so a sponsor pays for the modules they use, for the users who use them, and for the months they use them. Pricing is quoted against your protocol — request a demo and we will scope it with you.

Question 4

How long does it take to deploy Medify?

Accepted Answer

Medify deploys in 4 to 6 weeks, compared to 6 to 12 months for enterprise clinical trial platforms. This includes platform configuration, protocol setup, user training, and 30-day post-deployment support.

Question 5

What regulatory standards does Medify comply with?

Accepted Answer

Medify is designed for compliance with ICH-GCP E6(R3), ICH E2A, FDA 21 CFR Part 11, EU Annex 11, GDPR, EU MDR 2017/745, and EU Clinical Trials Regulation 536/2014. The platform includes an immutable audit trail, electronic signatures, role-based access control, and multi-factor authentication.

Question 6

How does Medify differ from Medidata or Veeva?

Accepted Answer

Medify occupies a different product category from enterprise CTMS platforms like Medidata and Veeva. While those focus on operational logistics and data management for large pharma, Medify bridges patients, investigators, and monitors through real-time data capture at the point of care. It deploys in weeks rather than months, costs a fraction of enterprise pricing, uses a modular pay-for-what-you-need model, and is specifically built for the Central and Eastern European clinical research market.

Question 7

What markets does Medify serve?

Accepted Answer

Medify's beachhead market is Bulgaria, expanding to Central and Eastern Europe including Romania, Serbia, Croatia, and the broader Balkans. The platform includes native Bulgarian localization and European data residency on AWS EU infrastructure. Western European expansion via CRO partnerships is planned for 2027 to 2028.

Question 8

What modules does Medify include?

Accepted Answer

Medify has five modules on a shared data layer: Patient Trial Hub (mobile app for enrollment, daily check-ins, medication tracking, and adverse event reporting), Investigator Dashboard (unified patient data, safety monitoring, compliance alerts), Monitor Control Center (multi-trial oversight, risk-based monitoring, query management), Safety Module (AE/SAE recording, severity assessment, escalation workflows), and eSource and Audit Trail (immutable audit log, electronic signatures, CDISC ODM export). Each module runs independently, and a protocol activates only the ones it needs.

Question 9

What traction does Medify have?

Accepted Answer

Medify has participated in 8 startup competitions and won 3 awards across the Eastern European region. The team conducted 43 in-depth interviews with 27 clinical trial experts across 8 product iterations. MVP pilot testing achieved 78% daily active patient usage, 90% data quality scores, and 92% onboarding completion. Medify secured its first investment in March 2025 and was validated in the JA Bulgaria Beyond Pre-accelerator program.

See Medify on your own protocol.

A 15-minute scoping call

You share a synopsis

A demo built on your study

Tell us about the study